Key biomarkers for synaptic plasticity and neuronal growth, such as brain-derived neurotrophic factor (BDNF) and mammalian target of rapamycin (mTOR), exhibit significant alterations in MDD [4,10]. Here, MTOR is linked to major depressive disorder.